Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy, Sell, Hold: 7 stocks that analysts are watching today

      Sun Pharma, Tech Mahindra, and Indian Hotels, among others are being tracked by investors today.

    • Stay away from pharma space, exit Sun Pharma: Vijay Chopra

      Vijay Chopra of enochventures.com is of the view that one may stay away from pharma space.

    • Here are SP Tulsian's top trading picks

      In an interview to CNBC-TV18's Surabhi Upadhyay and Reema Tendulkar, SP Tulsian shared his outlook and readings on the fundamentals of the market and specific stocks.

    • Buy IndusInd Bank, sell Hindalco Industries below Rs 186: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com suggests buying IndusInd Bank and advises selling Hindalco Industries below Rs 186.

    • Why did pharmaceutical stocks take a hit today?

      Individual news flow along with negative outlook for the sector by Credit Suisse hit the sector. Frontline stocks tank, pulling down the markets further.

    • Sell Indian Oil Corporation, ONGC, Sun Pharma: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends selling Indian Oil Corporation, ONGC and Sun Pharma.

    • Sell Ceat, Sun Pharmaceutical; buy Kotak Mahindra Bank: Ashwani Gujral

      Ashwani Gujral, ashwanigujral.com is of the view that one can sell Ceat and Sun Pharmaceutical Industries and buy Kotak Mahindra Bank.

    • Support for Bank Nifty at 22400; Reliance Capital, PFC bearish plays: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, Nifty has support at 9350 and resistance at 9500 while Bank Nifty has support at 22400 and resistance at 22800.

    • Sell Tata Motors, Vedanta; buy Bajaj Finance: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can sell Tata Motors and Vedanta and can buy Bajaj Finance.

    • Buy Shree Cements; sell Sun Pharma, see lower levels in Tata Comm: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Shree Cements and sell Sun Pharma while one can stay away from Lupin.

    • Buy NTPC; sell Sun Pharmaceutical Industries, ITC: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com suggests buying NTPC and sell Sun Pharmaceutical Industries and ITC.

    • Exit Glenmark Pharma, says Rajat Bose

      Rajat Bose of rajatkbose.com advises exiting Glenmark Pharma.

    • Buy M&M Financial Services, Sun Pharmaceutical Industries; sell Tata Motors, avoid VRL Logistics: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy M&M Financial Services and Sun Pharmaceutical Industries and can sell Tata Motors while VRL Logistics is an avoid.

    • Problem with Sun Pharma may aggravate: Surajit Pal

    • Prefer Sun Pharmaceutical Industries, says Vijay Chopra

      Vijay Chopra of enochventures.com is of the view that one may prefer Sun Pharmaceutical Industries.

    • Bull's Eye: Buy Sun Pharma, Pidilite, Alembic, SRF; Sell CESC

      Jay Thakkar of Anand Rathi Securities is of the view that one may buy Alembic with a target of Rs 48.70.

    • Buy Can Fin Homes, HDFC Bank; sell Sun Pharmaceutical Industries: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com suggests buying Can Fin Homes and HDFC Bank and sell Sun Pharmaceutical Industries.

    • Sell Reliance Infra, Sun Pharma, Dish TV; buy Bharti Infratel: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can sell Reliance Infra, Sun Pharma and Dish TV and advises buying Bharti Infratel and JM Financial.

    • Sell Orchid Pharma on rally, says Vijay Chopra

      Vijay Chopra of enochventures.com advises selling Orchid Pharma.

    • Sell Aurobindo Pharma, Sun Pharma: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com suggests selling Aurobindo Pharma and Sun Pharma.

    • Buy, sell, hold: These 3 stocks are on analysts’ radar today

      Voltas, Navneet Education and Kotak Mahindra Bank are on the watch list of analysts. Meanwhile, insurance, pharma and autos are also in focus.

    • Buy Britannia Industries, Magma Fincorp; sell Sun Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Britannia Industries and Magma Fincorp and advises selling Sun Pharma.

    • Sell Sun Pharmaceutical Industries, Hindustan Unilever; buy Biocon: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com suggests selling Sun Pharmaceutical Industries and Hindustan Unilever and advises buying Biocon.

    • Stay invested in Sun Pharma: Shahina Mukadam

      Shahina Mukadam, Independent Market Expert is of the view that one may stay invested in Sun Pharmaceuticals.

    • Buy Sun Pharma, target Rs 1050: Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one may buy Sun Pharmaceutical.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347